Ben Solomon
SCIENTIFIC CHAIR
Ben Solomon - Medical Oncologist
MBBS FRACP PhD
Professor Ben Solomon is a Medical Oncologist at the Peter MacCallum Cancer Centre in Melbourne, Australia.
involved in practice-changing lung cancer clinical trials with novel inhibitors of ALK, ROS1, NTRK, BRAF, cMET, RET, and KRAS, including pivotal trials leading to the registration of drugs including crizotinib, ceritinib, lorlatinib, repotrectinib, and selpercatinib. He has more than 200 peer-reviewed publications and has been recognised as a Clarivate Highly Cited Researcher (2019, 2020, 2021, 2022).
Ben was elected to the International Association for the Study of Lung Cancer (IASLC) Board in 2023, and is also a Board member of the Cancer Council of Victoria.
